Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 27, 2012 FBO #3716
SOLICITATION NOTICE

65 -- Notice of Intent-Ortho-Clinical Diagnostics Reagents - EstimatedSchedule of Supplies

Notice Date
1/25/2012
 
Notice Type
Presolicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
 
ZIP Code
20892-5480
 
Solicitation Number
12-003874
 
Archive Date
2/18/2012
 
Point of Contact
Malinda Dehner, Phone: 301-594-6320
 
E-Mail Address
dehnerm@cc.nih.gov
(dehnerm@cc.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
Estimated list of supplies for one-year. This is a notice of intent to award a sole source purchase order and is not a request for competitive proposals under the authority of FAR 6.302-1. The government intends to solicit a quote and enter into a one year purchase order with Ortho-Clinical Diagnostics, Inc., Rochester, NY 08869-1424, DUNS# 796036473 for the acquisition of reagents used in patient and donor testing. The proposed vendor, Ortho Clinical Diagnostics Inc. (OCD) is the only known manufacturer of the OCD reagents that must be used with the OCD Provue instrumentation currently in place for blood testing at the National Institutes of Health, Transfusion Services Lab. The estimated supply schedule is attached to this announcement. The total value of the one year award shall not exceed $150,000. The requested reagents are used for compatibility testing performed on the OCD instrument, the Provue. These reagents are required to perform type, screens and cross matches necessary for patient testing prior to transfusion. Without these reagents patients in the Clinical Center cannot receive the transfusions necessary for their treatment per protocols at the National Institutes of Health. These items need to be awarded on/or before February 17, 2012 to ensure continued antigen and antibody testing of blood products. Small businesses are encouraged to respond to this notice if they are capable to meet the needs of this requirement. Written responses to this notice shall contain sufficient documentation to establish bonafide capability to fulfill the requirement. The Government shall consider all responses received prior to the close date of this announcement. Written responses to this notice shall contain sufficient documentation to establish bonafide capability to fulfill the requirements established above. All responses must be received no later than February 3, 2012, 12:00PM, eastern standard time. Please email Malinda Dehner, Contract Specialist, at dehnerm@cc.nih.gov with technical questions or written responses pertaining to this notice. No phone calls please.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/12-003874/listing.html)
 
Place of Performance
Address: 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN02660735-W 20120127/120125234400-bdd0895954487b4ff8bddce4b67417bb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.